Nonpharmacologic intervention in acute alcohol withdrawal

Area of Science:

• Emergency Medicine
• Pharmacology
• Psychiatry

Background:

• The efficacy of nonpharmacologic versus pharmacologic interventions for alcohol withdrawal remains unclear.
• Alcohol withdrawal syndrome (AWS) is a common clinical challenge in emergency departments.

Purpose of the Study:

• To compare the effectiveness of supportive care with and without lorazepam in treating mild to moderate alcohol withdrawal.
• To evaluate treatment failure rates and symptom progression using the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-A) scale.

Main Methods:

• A randomized, double-blind, placebo-controlled trial involving 41 outpatients with alcohol withdrawal.
• Participants received either supportive care plus sublingual lorazepam or supportive care plus placebo over a 7-hour initial phase.
• Clinical assessments using the CIWA-A scale were performed hourly, followed by supportive care and drug/placebo administration.

Main Results:

• Ninety-two percent of patients improved during the initial phase, regardless of treatment group.
• Treatment failure (CIWA-A > 10) was more frequent in the placebo group (15%) compared to the lorazepam group (4.8%).
• Lorazepam showed a marginally faster improvement in CIWA-A scores within the first two hours, with similar follow-up scores between groups.

Conclusions:

• Outpatients with mild to moderate alcohol withdrawal without complications often improve with supportive care alone in the emergency department.
• While lorazepam may offer a slight, transient benefit, nonpharmacologic interventions appear sufficient for many patients.
• Further research could explore optimal supportive care protocols and patient selection for pharmacologic intervention.